UIATS在破裂颅内动脉瘤多中心队列中的回顾性应用:治疗选择导向评估
结果显示仅27.4%患者会获得治疗建议,31.5%建议保守管理,41.1%为不明确推荐;UIATS敏感性在27%至68%之间,最高72.6%最终破裂患者的动脉瘤可能被UIATS遗漏治疗推荐。
要点
- UIATS对最终破裂动脉瘤的治疗推荐敏感性有限,仅27.4%获治疗建议。
- 41.1%患者UIATS推荐不明确,敏感性随分组方式在27%至68%波动。
- 需前瞻性长期研究评估UIATS在真实临床实践中的可靠性。
核心结论
- UIATS在最终破裂的动脉瘤患者中未能对高达72.6%的病例提供明确的治疗推荐。
- 本研究提供额外证据表明部分未破裂颅内动脉瘤可能逃逸UIATS的敏感性。
研究设计与样本
- 回顾性多中心队列研究,纳入两个转诊脑血管中心收治的动脉瘤性蛛网膜下腔出血患者。
主要发现
- 40例(27.4%)患者UIATS建议治疗,平均评分4.58 ± 1.32。
- 46例(31.5%)患者UIATS建议保守管理,平均评分-7.07 ± 4.15。
- 60例(41.1%)患者UIATS推荐不明确,平均评分0.07 ± 1.42。
- UIATS敏感性在27%至68%之间,取决于是否将推荐不明确患者归入保守或干预组。
关键数值与推荐
- UIATS建议治疗组平均评分4.58 ± 1.32(40例,27.4%)。
- UIATS建议保守管理组平均评分-7.07 ± 4.15(46例,31.5%)。
- UIATS推荐不明确组平均评分0.07 ± 1.42(60例,41.1%)。
- UIATS敏感性范围27%至68%,依不明确推荐分组方式而异。
临床怎么用
- 临床决策中应用UIATS时应警惕其对部分最终破裂动脉瘤的低敏感性。
- UIATS推荐不明确比例较高,需结合其他临床与影像因素综合判断。
局限性
- 本研究为回顾性设计,样本来自两个转诊中心。
- 原文未报告长期前瞻性验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Decisions to treat unruptured intracranial aneurysms remain challenging, as the risk of rupture needs to be balanced with risk of intervention. In 2015, the Unruptured Intracranial Aneurysm Treatment Score (UIATS) was introduced to assist physicians in the decision making process. As its reliability is still debated, we retrospectively applied UIATS to a multicenter cohort of aneurysmal subarachnoid hemorrhage patients to test its performance in suggesting treatment in patients with known natural history. METHODS: Demographical, clinical, and radiological data of subarachnoid patients admitted in 2 referral cerebrovascular centers were collected. UIATS was individually calculated for each patient, and resulting recommendations were pooled in 3 groups (favor treatment, favor conservative management, unclear indication). RESULTS: One-hundred and forty-six patients were included in this study. In the event of aneurysm discovery previous to their rupture, UIATS calculation revealed that 40 (27.4%) patients would have received an indication-to-treat advice (mean score: 4.58 ± 1.32), 46 (31.5%) would have been suggested a conservative management (mean score: -7.07 ± 4.15), and 60 (41.1%) would have been included in an unclear recommendation group (mean score: 0.07 ± 1.42). UIATS sensitivity ranged between 27% and 68% depending on the inclusion of patients with unclear indication within the conservative or intervention group. CONCLUSIONS: In our study, UIATS would have failed to provide a clear recommendation to treat in up to 72.6% of patients whose aneurysm eventually ruptured. In agreement with previous reports, we provide additional evidence that some unruptured intracranial aneurysms may elude UIATS sensitivity. Further long-term prospective studies are necessary to assess UIATS reliability in real-world clinical practice.
引用
- Stumpo V, Latour K, Trevisi G, et al. Retrospective Application of UIATS Recommendations to a Multicenter Cohort of Ruptured Intracranial Aneurysms: How It Would Have Oriented the Treatment Choices? World Neurosurg. 2020. PMID: 33326858. doi:10.1016/j.wneu.2020.12.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。